Welcome to our dedicated page for Aterian SEC filings (Ticker: ATER), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Aterian, Inc. (Nasdaq: ATER) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a Delaware corporation with publicly traded common stock, Aterian submits periodic and current reports that offer detail on its financial condition, operations, governance, and material events affecting the business.
Investors can review Aterian’s current reports on Form 8-K, which in the supplied data include earnings announcements for quarters ended June 30 and September 30, 2025, amendments to its Credit and Security Agreement, and disclosures related to executive and director changes. Other 8-K filings describe the company’s entry into a material definitive agreement with its lenders and the furnishing of press releases that summarize financial results and guidance.
The company’s definitive proxy statement on Schedule DEF 14A outlines matters submitted to stockholders at the 2025 annual meeting, such as the election of directors, ratification of the independent registered public accounting firm, and advisory votes on executive compensation and the frequency of such votes. This document also explains record dates, voting procedures, and other governance details.
Over time, Aterian’s filings set is expected to include annual reports on Form 10-K, quarterly reports on Form 10-Q, additional Forms 8-K, and related exhibits. On Stock Titan, AI-powered tools can help summarize lengthy filings, highlight key sections on liquidity, credit agreements, and governance decisions, and make it easier to understand how individual disclosures fit into Aterian’s broader financial and strategic picture. Users can also monitor new filings as they are posted to EDGAR, including any future documents related to the company’s announced review of strategic alternatives.